Strive Health, LLC

Based in the US, Strive Health LLC operates as a healthcare company dedicated to transforming kidney care through innovative solutions addressing chronic kidney disease and end-stage kidney disease. Strive Health LLC specializes in kidney care solutions and was founded in 2018 in Denver, US. The founders include Bob Badal, David Whelan, and Will Stokes, with Chris Riopelle serving as CEO. The company has raised a total of USD 166.

00 mn through 4 funding deals, with the latest being a Series C round led by New Enterprise Associates, involving investors such as Ascension, CVS Health Ventures, and others. In September 2025, Strive Health LLC raised USD 300 million in series D funding led by returning investor New Enterprise Associates, with participation from other returning investors CapitalG, CVS Health Ventures, Echo Health Ventures, Redpoint Ventures, and Town Hall Ventures. New investor BlackRock and other unspecified investors also participated in the round. The round was part of a larger USD 550 million series D and venture debt funding.

Strive Health specializes in transforming kidney care through a suite of innovative products and services designed for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). Their core offerings include nephrologist-led comprehensive care programs supported by a nurse practitioner-led, multispecialty team of clinicians. Additionally, Strive Health utilizes its kidney disease-specific machine-learning platform, CareMultiplier™, to provide predictive insights that help clinicians develop individualized care plans aimed at optimizing patient outcomes. These services are targeted at health systems, payors, and nephrologists, enhancing patient care in a value-based healthcare environment.

Strive Health's revenue model is structured around partnerships with healthcare payors and providers, facilitating value-based care delivery for patients with kidney-related conditions. Revenue is generated through subscription agreements and collaborative contracts that cover service provision and shared risk arrangements. The company's flagship offerings, including CareMultiplier™, are integrated into existing healthcare frameworks, supporting clients in managing financial risks associated with kidney care. Strive Health LLC plans to expand its product offerings and enhance its technology to further support kidney care solutions.

The recent funding will be directed toward developing new products aimed at improving patient outcomes and expanding into new geographic markets with high kidney disease prevalence by 2024. Strive Health is particularly focused on enhancing its machine-learning capabilities to better serve health systems and nephrologists in managing chronic kidney diseases. The company will use the funding to expand kidney care through early detection, technology, and provider partnerships.